Poultry coccidiosis is a common and economically significant disease that affects poultry worldwide. Current treatment options for coccidiosis include using chemical agents such as ionophores and antiparasitic such as Metronidazole. However, there is growing interest in alternative treatments, such as herbal medicines, due to concerns about antiparasitic resistance and residues in poultry products. This review article aims to provide an overview of herbal medicines as potential treatments for poultry coccidiosis. The article summarizes the current research on herbal medicines for coccidiosis and highlights the potential benefits and limitations of using herbal medicines as an alternative to conventional treatments. The article explores the effectiveness of various herbal medicines in treating poultry coccidiosis, explaining how they work and presenting research findings on their efficacy. It also addresses challenges related to using herbal medicines, such as establishing standardized doses and conducting clinical trials. The review concludes by summarizing the main points and recommending further research on herbal medicines for poultry coccidiosis. Ultimately, the review underscores the potential of herbal medicines as alternative treatments and emphasizes the importance of continued investigation in this field.
Hydatid cyst disease is a serious parasitic infection caused by the larvae of the tapeworm Echinococcus granulosus. The disease affects millions of people worldwide, especially in regions, where dogs are used for livestock herding. Treating hydatid cysts is difficult and often involves invasive surgical procedures that risk complications. Mesenchymal stem cell (MSC) therapy has emerged as a promising new approach for treating hydatid cyst disease. This study aimed to explore the properties and therapeutic potential of MSCs, their role in the treatment of hydatid cyst disease, and the advantages of using MSC therapy in comparison with traditional treatment methods. The MSCs are adult stem cells found in various tissues, including bone marrow, adipose tissue, and umbilical cord tissue. The MSCs can differentiate into various cell types and modulate the immune response. This makes them a potentially valuable tool for treating infectious diseases, including hydatid cyst disease. Several studies have shown that MSC therapy can improve the outcomes of hydatid cyst disease. The MSCs were able to significantly reduce the cysts' size and decrease the levels of pro-inflammatory cytokines. The MSC therapy has several advantages rather to traditional treatment methods for hydatid cyst disease. The MSC therapy is minimally invasive and carries a lower risk of complications than surgical procedures. MSC therapy can also be combined with other treatments, such as albendazole, to improve the efficacy of the treatment. In conclusion, MSC therapy could revolutionize the treatment of hydatid cyst disease. More research is needed to fully understand MSC therapy's mechanisms and optimize the treatment protocols. However, the promising results of initial studies suggest that MSC therapy may become an important tool in the fight against hydatid cyst disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.